Changes in CB1and CB2receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Changes in CB1and CB2receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 6, Pages 1472-1489
Publisher
Wiley
Online
2013-08-14
DOI
10.1111/bph.12283
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Concise Guide to PHARMACOLOGY 2013/14: Overview
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB1 and CB2 Receptors
- (2012) Sara Valdeolivas et al. ACS Chemical Neuroscience
- Brain pathology of spinocerebellar ataxias
- (2012) Kay Seidel et al. ACTA NEUROPATHOLOGICA
- Cell biology of spinocerebellar ataxia
- (2012) Harry T. Orr JOURNAL OF CELL BIOLOGY
- The cerebellar component of Friedreich’s ataxia
- (2011) Arnulf H. Koeppen et al. ACTA NEUROPATHOLOGICA
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
- (2011) C García et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prospects for cannabinoid therapies in basal ganglia disorders
- (2011) Javier Fernández-Ruiz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Update on degenerative ataxias
- (2011) Thomas Klockgether CURRENT OPINION IN NEUROLOGY
- Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease
- (2011) Onintza Sagredo et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?
- (2011) P. Pacher et al. PROGRESS IN LIPID RESEARCH
- CB2: a cannabinoid receptor with an identity crisis
- (2010) Brady K Atwood et al. BRITISH JOURNAL OF PHARMACOLOGY
- The endocannabinoid system as a target for the treatment of neuronal damage
- (2010) Javier Fernández-Ruiz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond
- (2010) Alexandra Durr LANCET NEUROLOGY
- Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
- (2009) Javier Palazuelos et al. BRAIN
- The endocannabinoid system as a target for the treatment of motor dysfunction
- (2009) Javier Fernández-Ruiz BRITISH JOURNAL OF PHARMACOLOGY
- WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2009) David A. Price et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Cannabinoid CB2receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease
- (2009) Onintza Sagredo et al. GLIA
- Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells
- (2009) María Salazar et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei
- (2008) Juan Suárez et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Glial expression of cannabinoid CB2 receptors and fatty acid amide hydrolase are beta amyloid–linked events in Down’s syndrome
- (2008) E. Núñez et al. NEUROSCIENCE
- Cannabinoid CB2receptors in human brain inflammation
- (2007) C Benito et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now